Related Experiment Video
Updated: Sep 10, 2025

04:19
Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
580
An International Delphi Consensus on Defining the Optimal Surgical Composite Outcome in Metastatic Spine Disease
Rafael De la Garza Ramos1, C Rory Goodwin2, Michael H Weber3
1Department of Neurological Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY.
Spine
|August 25, 2025
Summary
An international expert consensus defined the Optimal Surgical Composite Outcome Measure (OSCO-M) for spinal metastases. This new measure includes surgical safety, functional status, and mobility to improve patient care quality.
Area of Science:
- Oncology
- Neurosurgery
- Surgical Outcomes Research
Background:
- Metastatic spine disease presents complex challenges in surgical management.
- Existing outcome measures may not fully capture the multidimensional aspects of surgical care in this population.
- There is a need for a standardized, consensus-driven outcome measure for oncologic spinal surgery.
Purpose of the Study:
- To establish an optimal surgical composite outcome measure (OSCO-M) for patients with metastatic spine disease.
- To achieve international consensus among key opinion leaders in spine oncology on a composite outcome measure.
- To define critical variables for assessing surgical success in spinal oncology.
Main Methods:
- A modified Delphi process involving international spine oncology experts was employed.
- The study involved two parts: identifying important outcome variables and defining successful outcomes.
- Consensus was defined as a 70% agreement threshold reached through questionnaires and consensus meetings.
Main Results:
- Forty-two international experts in spine oncology participated in the consensus process.
- A strong agreement (over 87%) was found regarding the utility of composite measures over individual variables.
- The OSCO-M was defined by three key variables: absence of severe adverse events (SAVES-V2 Grade ≥3) within 30 days, maintained/improved ECOG performance status at 90 days, and ambulation at 90 days.
Conclusions:
- This study presents the first consensus-derived composite outcome measure for oncologic surgery of spinal metastases.
- The developed OSCO-M provides a novel benchmark for evaluating surgical quality in spine tumor patients.
- The OSCO-M is expected to facilitate future research and optimize patient outcomes in metastatic spine disease management.
